Targeted overexpression of relaxin receptor 1 (RXFP1) with chronic administration of relaxin as a novel inotropic approach for heart failure treatment
Saved in:
Search Result 1
Targeted overexpression of relaxin receptor 1 (RXFP1) with chronic administration of relaxin as a novel inotropic approach for heart failure treatment
03 Nov. 2020
- Resolving-System, kostenfrei
- Resolving-System, kostenfrei
- Verlag, kostenfrei, Volltext
- Resolving-System
- Langzeitarchivierung Nationalbibliothek
- Resolving-System
Book/Monograph
Thesis
Online Resource